Published in Int J Cancer on April 25, 2011
Targeting metastasis. Nat Rev Cancer (2016) 1.26
Glucocorticoid receptor activity contributes to resistance to androgen-targeted therapy in prostate cancer. Horm Cancer (2014) 1.14
Hinokitiol induces DNA damage and autophagy followed by cell cycle arrest and senescence in gefitinib-resistant lung adenocarcinoma cells. PLoS One (2014) 0.85
Mitogen-activated protein kinase kinase 4 (MAP2K4) promotes human prostate cancer metastasis. PLoS One (2014) 0.83
Delayed cell cycle progression in selenoprotein W-depleted cells is regulated by a mitogen-activated protein kinase kinase 4-p38/c-Jun NH2-terminal kinase-p53 pathway. J Biol Chem (2012) 0.82
Downregulation of phosphorylated MKK4 is associated with a poor prognosis in colorectal cancer patients. Oncotarget (2017) 0.75
Time-dependent transcriptional profiling links gene expression to mitogen-activated protein kinase kinase 4 (MKK4)-mediated suppression of omental metastatic colonization. Clin Exp Metastasis (2012) 0.75
Selective glucocorticoid receptor modulators (SGRMs) delay castrate-resistant prostate cancer growth. Mol Cancer Ther (2017) 0.75
Cancer statistics, 2010. CA Cancer J Clin (2010) 103.28
The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer (2003) 22.78
Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer (2002) 17.49
KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science (1995) 3.97
Phenotypic heterogeneity of end-stage prostate carcinoma metastatic to bone. Hum Pathol (2003) 3.17
Persistence of solitary mammary carcinoma cells in a secondary site: a possible contributor to dormancy. Cancer Res (2002) 2.36
Cell lines used in prostate cancer research: a compendium of old and new lines--part 1. J Urol (2005) 2.36
Extracellular matrix: a gatekeeper in the transition from dormancy to metastatic growth. Eur J Cancer (2010) 2.13
The Drg-1 gene suppresses tumor metastasis in prostate cancer. Cancer Res (2003) 2.01
Cancer micrometastasis and tumour dormancy. APMIS (2008) 1.78
Disseminated tumor cells in prostate cancer patients after radical prostatectomy and without evidence of disease predicts biochemical recurrence. Clin Cancer Res (2009) 1.69
The current state of preclinical prostate cancer animal models. Prostate (2008) 1.68
Establishment and characterization of seven Dunning rat prostatic cancer cell lines and their use in developing methods for predicting metastatic abilities of prostatic cancers. Prostate (1986) 1.65
Genetic disparity between primary tumours, disseminated tumour cells, and manifest metastasis. Int J Cancer (2010) 1.60
Cell lines used in prostate cancer research: a compendium of old and new lines--part 2. J Urol (2005) 1.46
The p38 kinases MKK4 and MKK6 suppress metastatic colonization in human ovarian carcinoma. Cancer Res (2006) 1.43
Mitogen-activated protein kinase kinase 4/stress-activated protein/Erk kinase 1 (MKK4/SEK1), a prostate cancer metastasis suppressor gene encoded by human chromosome 17. Cancer Res (1999) 1.43
Rising prostate-specific antigen after primary prostate cancer therapy. Nat Clin Pract Urol (2005) 1.39
Modeling metastasis biology and therapy in real time in the mouse lung. J Clin Invest (2010) 1.32
Genomic alterations indicate tumor origin and varied metastatic potential of disseminated cells from prostate cancer patients. Cancer Res (2008) 1.32
The Src-suppressed C kinase substrate, SSeCKS, is a potential metastasis inhibitor in prostate cancer. Cancer Res (2001) 1.27
CD44 is a metastasis suppressor gene for prostatic cancer located on human chromosome 11p13. Cancer Res (1997) 1.25
Early tumor cell dissemination in patients with clinically localized carcinoma of the prostate. Clin Cancer Res (1997) 1.23
Suppression of metastatic colonization by the context-dependent activation of the c-Jun NH2-terminal kinase kinases JNKK1/MKK4 and MKK7. Cancer Res (2005) 1.21
Mitogen-activated protein kinase kinase 4 metastasis suppressor gene expression is inversely related to histological pattern in advancing human prostatic cancers. Cancer Res (2001) 1.18
The Dunning model. Prostate (2000) 1.02
Localization of metastasis suppressor gene(s) for prostatic cancer to the short arm of human chromosome 11. Cancer Res (1992) 1.01
Up-regulation of MKK4, MKK6 and MKK7 during prostate cancer progression: an important role for SAPK signalling in prostatic neoplasia. J Pathol (2007) 0.99
Effect of drug efflux blockers on vital staining of cellular DNA with Hoechst 33342. Cytometry (1987) 0.94
New paradigms for the function of JNKK1/MKK4 in controlling growth of disseminated cancer cells. Cancer Lett (2008) 0.90
Chromosome 17-mediated dormancy of AT6.1 prostate cancer micrometastases. Cancer Res (1998) 0.88
Functional evidence for a metastasis suppressor gene for rat prostate cancer within a 60-kilobase region on human chromosome 8p21-p12. Cancer Res (2002) 0.88
c-Jun NH2-terminal kinase activating kinase 1/mitogen-activated protein kinase kinase 4-mediated inhibition of SKOV3ip.1 ovarian cancer metastasis involves growth arrest and p21 up-regulation. Cancer Res (2008) 0.87
Activation of the tumor metastasis suppressor gene, KAI1, by etoposide is mediated by p53 and c-Jun genes. Biochem Biophys Res Commun (2000) 0.86
Localization of a novel tumor metastasis suppressor region on the short arm of human chromosome 2. Genes Chromosomes Cancer (2000) 0.80
Suppression of metastasis of rat prostate cancer by introduction of human chromosome 13. Asian J Androl (2002) 0.80
Cellular proliferation and prevalence of micrometastatic cells in the bone marrow of patients with clinically localized prostate cancer. Clin Cancer Res (1999) 0.79
Mechanisms of metastasis suppression by introduction of human chromosome 10 into rat prostate cancer. Asian J Androl (2002) 0.78
Flow cytometric evaluation of erythrocyte response to oxidant stress. Cytometry (1995) 0.78
Metastasis suppressor gene(s) for rat prostate cancer on the long arm of human chromosome 7. Genes Chromosomes Cancer (1999) 0.77
UPR pathways combine to prevent hepatic steatosis caused by ER stress-mediated suppression of transcriptional master regulators. Dev Cell (2008) 4.26
Common variants at 10 genomic loci influence hemoglobin A₁(C) levels via glycemic and nonglycemic pathways. Diabetes (2010) 4.07
Screening for lung cancer with CT: a preliminary cost-effectiveness analysis. Chest (2002) 2.88
Preparedness of the CTSA's structural and scientific assets to support the mission of the National Center for Advancing Translational Sciences (NCATS). Clin Transl Sci (2012) 1.76
Stillbirth and newborn mortality in India after helping babies breathe training. Pediatrics (2013) 1.42
Frequency of esophageal stenosis after simultaneous modulated accelerated radiation therapy and chemotherapy for head and neck cancer. Am J Otolaryngol (2007) 1.23
Imaging gastrointestinal stromal tumors. Cancer Control (2005) 1.22
FYN is overexpressed in human prostate cancer. BJU Int (2008) 1.22
Glucocorticoid receptor activity contributes to resistance to androgen-targeted therapy in prostate cancer. Horm Cancer (2014) 1.14
Increased gene copy number of ERG on chromosome 21 but not TMPRSS2-ERG fusion predicts outcome in prostatic adenocarcinomas. Mod Pathol (2011) 1.14
Duodenal varices: a novel treatment and literature review. Am Surg (2002) 1.13
Implementing a simplified neonatal resuscitation protocol-helping babies breathe at birth (HBB) - at a tertiary level hospital in Nepal for an increased perinatal survival. BMC Pediatr (2012) 1.09
Solitary ureteral metastases of renal cell carcinoma. Urology (2006) 1.08
Small endoscopic biopsies of the ureter and renal pelvis: pathologic pitfalls. Am J Surg Pathol (2009) 1.05
Societal interactions in ovarian cancer metastasis: a quorum-sensing hypothesis. Clin Exp Metastasis (2008) 0.98
Well-differentiated papillary mesothelioma occurring in the tunica vaginalis of the testis with contralateral atypical mesothelial hyperplasia. Urol Oncol (2006) 0.97
Milky spots promote ovarian cancer metastatic colonization of peritoneal adipose in experimental models. Am J Pathol (2013) 0.95
Using metastasis suppressor proteins to dissect interactions among cancer cells and their microenvironment. Cancer Metastasis Rev (2008) 0.95
The unfolded protein response represses differentiation through the RPD3-SIN3 histone deacetylase. EMBO J (2004) 0.93
IRE1- and HAC1-independent transcriptional regulation in the unfolded protein response of yeast. Mol Microbiol (2003) 0.92
New paradigms for the function of JNKK1/MKK4 in controlling growth of disseminated cancer cells. Cancer Lett (2008) 0.90
New roles for the RB tumor suppressor protein. Curr Opin Genet Dev (2004) 0.90
Mitogen-activated protein kinase kinase 4/c-Jun NH2-terminal kinase kinase 1 protein expression is subject to translational regulation in prostate cancer cell lines. Mol Cancer Res (2008) 0.90
c-Jun NH2-terminal kinase activating kinase 1/mitogen-activated protein kinase kinase 4-mediated inhibition of SKOV3ip.1 ovarian cancer metastasis involves growth arrest and p21 up-regulation. Cancer Res (2008) 0.87
Concurrent platinum-based chemotherapy and simultaneous modulated accelerated radiation therapy for locally advanced squamous cell carcinoma of the tongue base. Head Neck (2008) 0.84
Aberrant expression of p63 in adenocarcinoma of the prostate: a radical prostatectomy study. Am J Surg Pathol (2013) 0.82
Functional and anatomic imaging of tumor vasculature: high-resolution MR spectroscopic imaging combined with a superparamagnetic contrast agent. Acad Radiol (2002) 0.82
Adequacy of plain radiography in the diagnosis of cervical spine injuries. Emerg Radiol (2005) 0.81
Re: Accuracy of screening mammography interpretation by characteristics of radiologists. J Natl Cancer Inst (2005) 0.80
Using MKK4's metastasis suppressor function to identify and dissect cancer cell-microenvironment interactions during metastatic colonization. Cancer Metastasis Rev (2012) 0.80
A broad survey of cathepsin K immunoreactivity in human neoplasms. Am J Clin Pathol (2013) 0.79
Different ataxin-2 antibodies display different immunoreactive profiles. Brain Res (2004) 0.79
Ultrasound elastography as a tool for imaging guidance during prostatectomy: initial experience. Med Sci Monit (2012) 0.79
Technical note: the effect of the 4-mm-collimator output factor on gamma knife dose distributions. J Appl Clin Med Phys (2003) 0.77
Cost-effectiveness of screening for lung cancer. JAMA (2003) 0.77
Assessment of the LapraTy clip for facilitating reconstructive laparoscopic surgery in a porcine model. Urology (2007) 0.77
Efficacy of the argon beam coagulator alone in obtaining hemostasis after laparoscopic porcine heminephrectomy: a pilot study. Can J Urol (2008) 0.76
Definitions of respiratory events in sleep-disordered breathing. Sleep Med (2002) 0.75
Comment on "Nutritional gain versus financial gain: the role of metabolic carts in the surgical ICU". J Trauma (2007) 0.75
Is it time to revisit a role for antithrombotic therapy in asphyxia neonatorum? Pediatr Crit Care Med (2004) 0.75
Autologous endometrial coculture in patients with IVF failure: outcome of the first 1,030 cases. J Reprod Med (2004) 0.75
Building on the foundation of daring hypotheses: using the MKK4 metastasis suppressor to develop models of dormancy and metastatic colonization. FEBS Lett (2011) 0.75
Metastasis suppressor genes: signal transduction, cross-talk and the potential for modulating the behavior of metastatic cells. Anticancer Drugs (2004) 0.75
731: ASSESSMENT OF GLYMPHATIC FLUX IN A PEDIATRIC RODENT MODEL OF INTRACRANIAL HYPERTENSION. Crit Care Med (2016) 0.75
The complete denture crisis: a personal view. Eur J Prosthodont Restor Dent (2005) 0.75
Digital intraoral imaging: a beneficial patient education tool. Compend Contin Educ Dent (2015) 0.75
Standardization for image characteristics in telemammography using genetic and nonlinear algorithms. Comput Biol Med (2005) 0.75
The effects of false physiological feedback on tumescence and cognitive domains in sexually functional and dysfunctional men. Arch Sex Behav (2008) 0.75
775: SERUM BIOMARKER-BASED MODELS TO PREDICT INTRACRANIAL PRESSURE IN PEDIATRIC TRAUMATIC BRAIN INJURY. Crit Care Med (2016) 0.75
866: PHARMACOGENOMIC-BASED EVALUATION OF FENTANYL REQUIREMENTS IN DIAGNOSTICALLY DIVERSE PICU PATIENTS. Crit Care Med (2016) 0.75
721: MICROGLIAL ACTIVATION CORRELATES WITH CYTOTOXIC EDEMA IN A MURINE MODEL OF SEPSIS. Crit Care Med (2016) 0.75
Correlation of the Voice Handicap Index (VHI) and the Voice-Related Quality of Life Measure (V-RQOL). J Voice (2006) 0.75
743: ACUTE INFLAMMATORY RESPONSE TO TRAUMATIC BRAIN INJURY IS AFFECTED BY MODULATORS OF GUT MICROBIOTA. Crit Care Med (2016) 0.75